Beam Therapeutics BEAM Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $288.29M-45.4% | $294.94M+4.6% | $267.96M+16.4% | $282.13M-3.6% | $527.91M+83.4% | ||
| $923.36M+33.4% | $950.27M+67.1% | $807.01M+16.0% | $868.21M+21.4% | $692.05M-14.2% | ||
| $6.69M+1.3% | $6.68M-18.0% | $6.66M+1.6% | $6.63M+7.8% | $6.61M+2.4% | ||
| $55.3M+99.9% | $23.48M-14.3% | $23.58M+19.2% | $25.13M+18.1% | $27.66M+1.9% | ||
| $1.27B+1.6% | $1.27B+44.5% | $1.1B+16.2% | $1.18B+14.2% | $1.25B+11.2% | ||
| $101.25M-7.6% | $104.5M-6.2% | $108.29M-4.6% | $108.82M-7.4% | $109.57M-9.4% | ||
| $98.15M-4.0% | $100.68M-4.0% | $97M-7.4% | $99.57M-6.8% | $102.22M-6.2% | ||
| $7.76M+751% | $634K-49.4% | $593K-45.0% | $668K-49.5% | $911K-46.1% | ||
| $1.48B+0.9% | $1.48B+34.2% | $1.31B+11.9% | $1.39B+10.3% | $1.47B+7.9% | ||
| $12.29M+59.6% | $10.23M+164% | $9.55M+150% | $10.56M+138% | $7.7M+176% | ||
| $39.29M+30.0% | $55.27M+16.4% | $42.31M-18.3% | $40.9M-39.1% | $30.23M-65.0% | ||
| $304K-99.6% | $6.66M-93.9% | $110.32M+23.5% | $105.82M+24.6% | $85.2M+18.2% | ||
| $14.78M+11.9% | $14.36M+6.6% | $12.69M-1.9% | $12.95M+2.4% | $13.21M+8.4% | ||
| $74.57M-47.3% | $96.94M-46.8% | $182.56M+9.8% | $174.13M-1.8% | $141.55M-24.4% | ||
| $100.19M— | —— | —— | —— | —— | ||
| $135.85M-6.3% | $139.76M-5.5% | $138.73M-7.0% | $141.85M-7.0% | $144.92M-7.1% | ||
| —— | —— | —— | —— | —— | ||
| $305K-26.3% | $173K-65.7% | $266K-44.7% | $357K-47.4% | $414K-42.4% | ||
| $316.36M-8.0% | $242.82M-34.4% | $345.08M-9.2% | $344.34M-15.4% | $343.78M-23.0% | ||
| $1.03M+2.1% | $1.02M+21.7% | $1.01M+22.8% | $1.01M+22.3% | $1.01M+22.2% | ||
| $2.9B+3.7% | $2.88B+25.2% | $2.86B+26.1% | $2.82B+26.4% | $2.8B+27.1% | ||
| -$1.74B-3.6% | -$1.64B-4.8% | -$1.89B-28.1% | -$1.78B-28.9% | -$1.68B-30.1% | ||
| -$1.07M-769% | $1.11M+63.6% | $790K-55.1% | $10K+101% | $160K+117% | ||
| $1.16B+3.1% | $1.24B+68.8% | $966M+22.1% | $1.05B+22.6% | $1.13B+23.6% | ||
| $1.48B+0.9% | $1.48B+34.2% | $1.31B+11.9% | $1.39B+10.3% | $1.47B+7.9% | ||
| $923.36M+33.4% | $950.27M+67.1% | $807.01M+16.0% | $868.21M+21.4% | $692.05M-14.2% | ||
| $7.76M+751% | $634K-49.4% | $593K-45.0% | $668K-49.5% | $911K-46.1% | ||
| $98.15M-4.0% | $100.68M-4.0% | $97M-7.4% | $99.57M-6.8% | $102.22M-6.2% | ||
| $98.15M-4.0% | $100.68M-4.0% | $97M-7.4% | $99.57M-6.8% | $102.22M-6.2% | ||
| $7.76M+751% | $634K-49.4% | $593K-45.0% | $668K-49.5% | $911K-46.1% | ||
| $98.15M-4.0% | $100.68M-4.0% | $97M-7.4% | $99.57M-6.8% | $102.22M-6.2% | ||
| $7.76M+751% | $634K-49.4% | $593K-45.0% | $668K-49.5% | $911K-46.1% | ||
| $5.2M0.0% | $7.7M-8.3% | $6.5M-22.6% | $3.9M-52.4% | $5.2M-62.0% | ||
| $5.2M0.0% | $7.7M-8.3% | $6.5M-22.6% | $3.9M-52.4% | $5.2M-62.0% | ||
| $5.45M+371% | $5.95M+426% | $6.71M+508% | $1.19M+10.1% | $1.16M-59.5% | ||
| $39.29M+30.0% | $55.27M+16.4% | $42.31M-18.3% | $40.9M-39.1% | $30.23M-65.0% | ||
| $250.82M+58.6% | $154.12M-4.5% | $151.42M-6.6% | $154.8M-6.3% | $158.13M-5.9% | ||
| $1.03M+2.1% | $1.02M+21.7% | $1.01M+22.8% | $1.01M+22.3% | $1.01M+22.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beam Therapeutics's total assets?
- Beam Therapeutics (BEAM) holds $1.5B in total assets, up 0.9% year over year.
- How much debt does Beam Therapeutics have?
- Beam Therapeutics carries $250.8M in total debt against $1.2B of shareholders' equity, a debt-to-equity ratio of 0.22.
- How much cash does Beam Therapeutics have?
- Beam Therapeutics holds $288.3M in cash and equivalents.
- Can Beam Therapeutics cover its short-term obligations?
- Its current ratio is 16.99 — current assets exceed current liabilities.
- Where does Beam Therapeutics's balance sheet data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
